138 related articles for article (PubMed ID: 33782741)
21. Core needle biopsy diagnosis of fibroepithelial lesions of the breast: a diagnostic challenge.
Li JJX; Tse GM
Pathology; 2020 Oct; 52(6):627-634. PubMed ID: 32771211
[TBL] [Abstract][Full Text] [Related]
22. A subset of malignant phyllodes tumors express p63 and p40: a diagnostic pitfall in breast core needle biopsies.
Cimino-Mathews A; Sharma R; Illei PB; Vang R; Argani P
Am J Surg Pathol; 2014 Dec; 38(12):1689-96. PubMed ID: 25046342
[TBL] [Abstract][Full Text] [Related]
23. Collagen type III α1 as a useful diagnostic immunohistochemical marker for fibroepithelial lesions of the breast.
Wang Y; Resnick MB; Lu S; Hui Y; Brodsky AS; Yang D; Yakirevich E; Wang L
Hum Pathol; 2016 Nov; 57():176-181. PubMed ID: 27498063
[TBL] [Abstract][Full Text] [Related]
24. Giant malignant phyllodes tumor: a case report.
Takenaka M; Toh U; Otsuka H; Takahashi H; Iwakuma N; Nakagawa S; Fujii T; Yamaguchi R; Yano H; Shirouzu K; Kage M
Kurume Med J; 2011; 58(2):67-72. PubMed ID: 22251824
[TBL] [Abstract][Full Text] [Related]
25. Core needle biopsy as a diagnostic tool to differentiate phyllodes tumor from fibroadenoma.
Komenaka IK; El-Tamer M; Pile-Spellman E; Hibshoosh H
Arch Surg; 2003 Sep; 138(9):987-90. PubMed ID: 12963656
[TBL] [Abstract][Full Text] [Related]
26. Genomic characterisation of breast fibroepithelial lesions in an international cohort.
Md Nasir ND; Ng CCY; Rajasegaran V; Wong SF; Liu W; Ng GXP; Lee JY; Guan P; Lim JQ; Thike AA; Koh VCY; Loke BN; Chang KTE; Gudi MA; Lian DWQ; Madhukumar P; Tan BKT; Tan VKM; Wong CY; Yong WS; Ho GH; Ong KW; ; Tan P; Teh BT; Tan PH
J Pathol; 2019 Dec; 249(4):447-460. PubMed ID: 31411343
[TBL] [Abstract][Full Text] [Related]
27. Phyllodes tumours of the breast diagnosed as B3 category on image-guided 14-gauge core biopsy: analysis of 51 cases from a single institution and review of the literature.
Abdulcadir D; Nori J; Meattini I; Giannotti E; Boeri C; Vanzi E; Vezzosi V; Bianchi S
Eur J Surg Oncol; 2014 Jul; 40(7):859-64. PubMed ID: 24612651
[TBL] [Abstract][Full Text] [Related]
28. Management of phyllodes breast tumors.
Guillot E; Couturaud B; Reyal F; Curnier A; Ravinet J; Laé M; Bollet M; Pierga JY; Salmon R; Fitoussi A;
Breast J; 2011; 17(2):129-37. PubMed ID: 21251125
[TBL] [Abstract][Full Text] [Related]
29. Cystosarcoma phyllodes of the breast: a rare diagnosis: case studies and review of literature.
Kraemer B; Hoffmann J; Roehm C; Gall C; Wallwiener D; Krainick-Strobel U
Arch Gynecol Obstet; 2007 Dec; 276(6):649-53. PubMed ID: 17549503
[TBL] [Abstract][Full Text] [Related]
30. Multinucleated giant cells in a breast fine needle aspirate.
Ho C; Duggan MA
Cytopathology; 2002 Aug; 13(4):247-53. PubMed ID: 12269898
[No Abstract] [Full Text] [Related]
31. Progression of Fibroadenoma to Malignant Phyllodes Tumour in a 14-Year Female.
Faridi SH; Siddiqui B; Ahmad SS; Aslam M
J Coll Physicians Surg Pak; 2018 Jan; 28(1):69-71. PubMed ID: 29290198
[TBL] [Abstract][Full Text] [Related]
32. Phyllodes tumor of breast.
Shabbir J; O'Sullivan JB; Mahmood S; Byrnes G
J Coll Physicians Surg Pak; 2003 Mar; 13(3):170-1. PubMed ID: 12689541
[TBL] [Abstract][Full Text] [Related]
33. Rare case of biphasic tumor of the breast with prominent CD34-positive spindle cells.
Hayashi M; Tamura G; Matsumoto O; Motoyama T
Pathol Int; 2001 Sep; 51(9):713-7. PubMed ID: 11696175
[TBL] [Abstract][Full Text] [Related]
34. Malignant phyllodes tumour: report of two cases.
Muthuphei MN
East Afr Med J; 1995 Dec; 72(12):818-20. PubMed ID: 8689987
[TBL] [Abstract][Full Text] [Related]
35. [A patient with pulmonary metastasis of phyllodes tumour of the breast].
Solberg OG; Blom GP; Stavem K
Tidsskr Nor Laegeforen; 2005 Nov; 125(21):2956-7. PubMed ID: 16299881
[TBL] [Abstract][Full Text] [Related]
36. Primary treatment of cystosarcoma phyllodes of the breast.
Chaney AW; Pollack A; McNeese MD; Zagars GK; Pisters PW; Pollock RE; Hunt KK
Cancer; 2000 Oct; 89(7):1502-11. PubMed ID: 11013364
[TBL] [Abstract][Full Text] [Related]
37. Surgical treatment of borderline and malignant phyllodes tumors: the effect of the extent of resection and tumor characteristics on patient outcome.
Onkendi EO; Jimenez RE; Spears GM; Harmsen WS; Ballman KV; Hieken TJ
Ann Surg Oncol; 2014 Oct; 21(10):3304-9. PubMed ID: 25034817
[TBL] [Abstract][Full Text] [Related]
38. Localization and hypersecretion of nerve growth factor in breast phyllodes tumors: Evidence from a preliminary study.
Kumar A; Raza K; Nag TC; Srivastava A; Sehgal R
Cancer Rep (Hoboken); 2021 Feb; 4(1):e1300. PubMed ID: 33026185
[TBL] [Abstract][Full Text] [Related]
39. Mammary fibroadenoma and some phyllodes tumour stroma are composed of CD34+ fibroblasts and factor XIIIa+ dendrophages.
Silverman JS; Tamsen A
Histopathology; 1996 Nov; 29(5):411-9. PubMed ID: 8951485
[TBL] [Abstract][Full Text] [Related]
40. Phyllodes tumours of the breast: Outcomes and recurrence after excision.
Wen B; Mousadoust D; Warburton R; Pao JS; Dingee C; Chen L; McKevitt E
Am J Surg; 2020 May; 219(5):790-794. PubMed ID: 32145921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
